|
C1ORF124 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.82179999999688E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.238600E-04 |
| Normal-vs-Stage2 |
3.462300E-02 |
| Normal-vs-Stage3 |
4.59750000003645E-06 |
| Normal-vs-Stage4 |
5.67079999624909E-08 |
| Stage1-vs-Stage2 |
7.768600E-01 |
| Stage1-vs-Stage3 |
4.570100E-02 |
| Stage1-vs-Stage4 |
1.882110E-03 |
| Stage2-vs-Stage3 |
4.265400E-01 |
| Stage2-vs-Stage4 |
1.208220E-01 |
| Stage3-vs-Stage4 |
2.411800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.54264999999709E-05 |
| Normal-vs-AfricanAmerican |
6.29810000000175E-05 |
| Normal-vs-Asian |
4.610400E-01 |
| Caucasian-vs-AfricanAmerican |
2.916400E-01 |
| Caucasian-vs-Asian |
4.702800E-01 |
| AfricanAmerican-vs-Asian |
2.487400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.81359999965147E-07 |
| Normal-vs-Female |
3.356600E-03 |
| Male-vs-Female |
1.705900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.378180E-03 |
| Normal-vs-Age(41-60Yrs) |
1.041810E-04 |
| Normal-vs-Age(61-80Yrs) |
1.56912000000009E-05 |
| Normal-vs-Age(81-100Yrs) |
1.171730E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.315400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.567800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.837200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.052600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.865400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.430600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.655800E-01 |
| Normal-vs-Grade 2 |
1.331870E-02 |
| Normal-vs-Grade 3 |
2.73879999790339E-08 |
| Normal-vs-Grade 4 |
1.85299999788668E-08 |
| Grade 1-vs-Grade 2 |
2.311600E-01 |
| Grade 1-vs-Grade 3 |
2.824600E-03 |
| Grade 1-vs-Grade 4 |
1.380830E-03 |
| Grade 2-vs-Grade 3 |
5.788900E-04 |
| Grade 2-vs-Grade 4 |
8.31319999999858E-05 |
| Grade 3-vs-Grade 4 |
1.026620E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.522180E-01 |
| Normal-vs-ccB subtype |
1.7640000005148E-07 |
| ccA subtype-vs-ccB subtype |
1.50830000000823E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.02089999999222E-05 |
| Normal-vs-N1 |
3.417400E-03 |
| N0-vs-N1 |
4.693200E-01 |
|
|
